Sanofi-Genzyme BioVentures
Overview
Sanofi Genzyme BioVentures is the corporate venture capital arm of Sanofi, focusing on early-stage investments in biotechnology and life sciences companies. The firm seeks to identify and support innovative companies that align with Sanofi's strategic interests, aiming to enhance the company's pipeline and foster external innovation. The investment strategy emphasizes sectors such as biotechnology, pharmaceuticals, healthcare, medical devices, diagnostics, and genomics. Sanofi Genzyme BioVentures invests across various stages, including seed, early stage, Series A, Series B, growth, late stage, and pre-IPO, with investment sizes ranging from $1 million to $50 million. The geographical focus spans multiple countries, including the United States, France, Germany, Italy, Spain, the United Kingdom, China, Japan, India, Brazil, Mexico, Canada, Australia, South Korea, Russia, South Africa, Saudi Arabia, Turkey, Argentina, and Chile. By leveraging Sanofi's global presence and expertise, Sanofi Genzyme BioVentures aims to accelerate the development of transformative therapies and address unmet medical needs worldwide. The firm's portfolio includes companies across various therapeutic areas, reflecting its commitment to advancing healthcare through strategic partnerships and investments.
Investment Focus
- Innovative biotechnology and life sciences companies
- Alignment with Sanofi's strategic interests
- Early-stage companies with promising new products
- Potential future pipeline candidates for Sanofi
Portfolio Companies
Reach Sanofi-Genzyme BioVentures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Sanofi-Genzyme BioVentures
What sectors does Sanofi-Genzyme BioVentures invest in?
Sanofi-Genzyme BioVentures invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Oncology, and is based in Cambridge, Massachusetts, United States. Sanofi-Genzyme BioVentures is listed as a corporate vc in the ConnectSafely investor database.
What stage does Sanofi-Genzyme BioVentures invest at?
Sanofi-Genzyme BioVentures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Sanofi-Genzyme BioVentures invest in?
Sanofi-Genzyme BioVentures invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Sanofi-Genzyme BioVentures invested in?
Sanofi-Genzyme BioVentures's portfolio includes SynthorX, Provention Bio, Sanofi Pasteur, Principia Biopharma, Voyager Therapeutics, Translate Bio, Kadmon Corporation and Protein Sciences Corporation.
Last updated · Source: ConnectSafely investor database
